Table 1. Univariate analysis of prognostic factors for gastric cancer patients with ovarian metastasis.
| Characteristics | n (%) | 1-year survival rate (%) | 3-year survival rate (%) | Median survival period (months) | χ2 | P |
|---|---|---|---|---|---|---|
| Age, years | 0.004 | 0.952 | ||||
| ≤50 | 46 (73.0) | 55.8 | 30.6 | 13.1 | ||
| >50 | 17 (27.0) | 44.7 | 19.1 | 10.3 | ||
| Menstrual history | 0.070 | 0.792 | ||||
| Pre-menopausal | 41 (65.1) | 57.1 | 5.9 | 12.6 | ||
| Post-menopausal | 22 (34.9) | 42.3 | 18.1 | 10.4 | ||
| Lymph node metastasis of gastric carcinoma | 3.013 | 0.083 | ||||
| N0-1 | 20 (31.7) | 72.6 | 16.8 | 12.9 | ||
| N2-3 | 43 (68.3) | 43.4 | 5.1 | 11.2 | ||
| Interval between metastatic and primary foci (months) | 0.159 | 0.690 | ||||
| ≤6 | 21 (33.3) | 42.8 | 15.3 | 9.8 | ||
| >6 | 42 (66.7) | 56.8 | 8.5 | 13.3 | ||
| Ovarian metastasis | 1.107 | 0.293 | ||||
| Unilateral | 9 (14.3) | 44.4 | 11.1 | 10.6 | ||
| Bilateral | 54 (85.7) | 54.3 | 11.5 | 11.5 | ||
| Size of metastatic foci (cm) | 2.785 | 0.095 | ||||
| >10 | 44 (69.8) | 56.9 | 11.5 | 12.8 | ||
| ≤10 | 19 (30.2) | 36.5 | 0 | 9.6 | ||
| Peritoneal seeding | 19.719 | <0.001 | ||||
| Yes | 46 (73.0) | 34.7 | 0 | 8.5 | ||
| No | 17 (27.0) | 88.2 | 30.5 | 20.7 | ||
| Histopathologic type of metastatic foci | 1.010 | 0.604 | ||||
| Signet ring cell carcinoma | 38 (60.3) | 50.0 | 19.9 | 10.5 | ||
| Tubular adenocarcinoma | 21 (33.3) | 57.9 | 0 | 13.2 | ||
| Mucinous adenocarcinoma | 4 (6.4) | 50.0 | 0 | 10.2 | ||
| Vascular tumor thrombus of metastatic foci | 2.676 | 0.049 | ||||
| Yes | 28 (44.4) | 44.8 | 6.2 | 9.6 | ||
| No | 35 (55.6) | 65.2 | 16.3 | 13.1 | ||
| Foci resection | 23.327 | <0.001 | ||||
| Total resection | 20 (31.7) | 89.5 | 27.3 | 19.4 | ||
| Palliative resection | 43 (68.3) | 33.7 | 0 | 8.8 | ||
| Therapeutic methods | 5.772 | 0.016 | ||||
| Surgery alone | 22 (34.9) | 40.0 | 0 | 9.8 | ||
| Surgery plus chemotherapy | 41 (65.1) | 59.8 | 15.5 | 15.2 |